Pathology of Epstein-Barr virus-associated gastric carcinoma and its relationship to prognosis

Gut and Liver

Volumn 5, Issue 2, 2011, Pages 143-148

  Song, Hye Jong ^a   Kim, Kyoung Mee ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Carcinoma; Epstein Barr virus; Pathology; Prognosis; Stomach

Indexed keywords

ADENOCARCINOMA; AGE; CANCER CLASSIFICATION; CANCER INVASION; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURVIVAL; CARDIA; CELLULAR IMMUNITY; CROHN DISEASE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; EPSTEIN BARR VIRUS; GENDER; GEOGRAPHIC DISTRIBUTION; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INNATE IMMUNITY; LYMPH NODE METASTASIS; LYMPHOEPITHELIOMA; MICROSCOPY; MOLECULAR MECHANICS; OVERALL SURVIVAL; PREVALENCE; PROGNOSIS; REVIEW; STOMACH ANTRUM; STOMACH CARCINOMA; STOMACH FUNDUS;

EID: 79959337956     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2011.5.2.143     Document Type: Review

References (30)

1. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004;4:757-768. (Pubitemid 39331148)
2. Delecluse HJ, Feederle R, O'Sullivan B, Taniere P. Epstein Barr virus-associated tumours: an update for the attention of the working pathologist. J Clin Pathol 2007;60:1358-1364. (Pubitemid 350247251)
3. Murphy G, Pfeiffer R, Camargo MC, Rabkin CS. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology 2009;137:824-833.
4. Morewaya J, Koriyama C, Akiba S, Shan D, Itoh T, Eizuru Y. Epstein-Barr virus-associated gastric carcinoma in Papua New Guinea. Oncol Rep 2004;12:1093-1098.
5. Ojima H, Fukuda T, Nakajima T, Takenoshita S, Nagamachi Y. Discrepancy between clinical and pathological lymph node evaluation in Epstein-Barr virus-associated gastric cancers. Anticancer Res 1996;16(5B):3081-3084. (Pubitemid 26390252)
6. Lee JH, Kim SH, Han SH, An JS, Lee ES, Kim YS. Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis. J Gastroenterol Hepatol 2009;24:354-365.
7. Corvalan A, Ding S, Koriyama C, et al. Association of a distinctive strain of Epstein-Barr virus with gastric cancer. Int J Cancer 2006;118:1736-1742. (Pubitemid 43376437)
8. Horiuchi K, Mishima K, Ohsawa M, Aozasa K. Carcinoma of stomach and breast with lymphoid stroma: localisation of Epstein-Barr virus. J Clin Pathol 1994;47:538-540. (Pubitemid 24294018)
9. Burke AP, Yen TS, Shekitka KM, Sobin LH. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol 1990;3:377-380.
10. Takada K. Epstein-Barr virus and gastric carcinoma. Mol Pathol 2000;53:255-261.
11. Park ES, Do IG, Park CK, et al. Cyclooxygenase-2 is an independent prognostic factor in gastric carcinoma patients receiving adjuvant chemotherapy and is not associated with EBV infection. Clin Cancer Res 2009;15:291-298.
12. Chang MS, Lee HS, Kim CW, Kim YI, Kim WH. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea. Pathol Res Pract 2001;197:395-400. (Pubitemid 32544902)
13. Gulley ML, Pulitzer DR, Eagan PA, Schneider BG. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. Hum Pathol 1996;27:20-27. (Pubitemid 26015577)
14. Song HJ, Srivastava A, Lee J, et al. Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma. Gastroenterology 2010;139:84-92+e2.
15. Akiba S, Koriyama C, Herrera-Goepfert R, Eizuru Y. Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features. Cancer Sci 2008;99:195-201. (Pubitemid 351228470)
16. Koriyama C, Akiba S, Itoh T, et al. Prognostic significance of Epstein-Barr virus involvement in gastric carcinoma in Japan. Int J Mol Med 2002;10:635-639.
17. Yanai H, Nishikawa J, Mizugaki Y, et al. Endoscopic and pathologic features of Epstein-Barr virus-associated gastric carcinoma. Gastrointest Endosc 1997;45:236-242. (Pubitemid 27423803)
18. Kim SW, Shin HC, Kim IY, et al. Epstein-Barr virus-associated lymphoepithelioma-like gastric carcinoma presenting as a submucosal mass: CT findings with pathologic correlation. Korean J Radiol 2010;11:697-700.
19. Nishikawa J, Yanai H, Mizugaki Y, Takada K, Tada M, Okita K. Case report: hypoechoic submucosal nodules. A sign of Epstein-Barr virus-associated early gastric cancer. J Gastroenterol Hepatol 1998;13:585-590. (Pubitemid 28407300)
20. Fukayama M. Epstein-Barr virus and gastric carcinoma. Pathol Int 2010;60:337-350.
21. Matsunou H, Konishi F, Hori H, et al. Characteristics of Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma in Japan. Cancer 1996;77:1998-2004. (Pubitemid 26142041)
22. Arikawa J, Tokunaga M, Tashiro Y, et al. Epstein-Barr virus-positive multiple early gastric cancers and dysplastic lesions: a case report. Pathol Int 1997;47:730-734. (Pubitemid 27460765)
23. Arikawa J, Tokunaga M, Satoh E, Tanaka S, Land CE. Morphological characteristics of Epstein-Barr virus-related early gastric carcinoma: a case-control study. Pathol Int 1997;47:360-367. (Pubitemid 27274208)
24. Lee HE, Chae SW, Lee YJ, et al. Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer. Br J Cancer 2008;99:1704-1711.
25. Grogg KL, Lohse CM, Pankratz VS, Halling KC, Smyrk TC. Lymphocyte-rich gastric cancer: associations with Epstein-Barr virus, microsatellite instability, histology, and survival. Mod Pathol 2003;16:641-651. (Pubitemid 36871496)
26. Ishigami S, Natsugoe S, Tokuda K, et al. Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer 2000;88:577-583. (Pubitemid 30056932)
27. van Beek J, zur Hausen A, Snel SN, et al. Morphological evidence of an activated cytotoxic T-cell infiltrate in EBV-positive gastric carcinoma preventing lymph node metastases. Am J Surg Pathol 2006;30:59-65.
28. Kuzushima K, Nakamura S, Nakamura T, et al. Increased frequency of antigen-specific CD8(+) cytotoxic T lymphocytes infiltrating an Epstein-Barr virus-associated gastric carcinoma. J Clin Invest 1999;104:163-171.
29. Chapel F, Fabiani B, Davi F, et al. Epstein-Barr virus and gastric carcinoma in Western patients: comparison of pathological parameters and p53 expression in EBV-positive and negative tumours. Histopathology 2000;36:252-261. (Pubitemid 30145253)
30. Chang MS, Lee JH, Kim JP, et al. Microsatellite instability and Epstein-Barr virus infection in gastric remnant cancers. Pathol Int 2000;50:486-492. (Pubitemid 30482394)